Is EDS a Trend? What Is Actually Happening — and Why It Matters
The frustration is real — on all sides.
If you have EDS, you have probably noticed something strange happening online. The condition you fought for years to have named — the one dismissed by specialist after specialist — is suddenly everywhere. And with that visibility has come something painful: people in your community starting to feel like their very real diagnosis is being cheapened.
Doctors who never diagnosed a single EDS case are now seeing five a week. Some are applying the label with limited knowledge. Others are dismissing it entirely because they've seen too many self-diagnoses and don't want to be part of what they see as a trend. And people who genuinely have EDS — who spent decades fighting to be believed — are caught in the middle of all of it, watching their diagnosis become a punchline or a hashtag.
Three distinct situations that are being conflated.
Much of the confusion comes from treating hypermobility, HSD, and EDS as interchangeable when they are not. Understanding the difference does not mean dismissing anyone's pain. It means having the right tools for the right situation.
Joint range of motion beyond normal limits. Can be entirely asymptomatic — a physical trait with no underlying connective tissue disorder. Common in the general population, especially in certain demographic groups and among athletes and dancers.
Hypermobility Spectrum Disorder. Symptomatic hypermobility that does not meet diagnostic criteria for EDS. Real pain, real functional impact, real condition — but distinct from EDS. Often underdiagnosed, rarely overdiagnosed.
Ehlers-Danlos Syndrome. A genetic connective tissue disorder with systemic effects. hEDS remains without a confirmed gene marker, which creates diagnostic complexity. Multi-system. Life-altering. In some subtypes, life-threatening.
A person who is very flexible and has no symptoms is not the same as a person with symptomatic hypermobility that limits their daily function. And neither is the same as a person with hEDS whose connective tissue disorder affects their joints, skin, autonomic nervous system, gut, and quality of life in profound ways. These are different situations that deserve different responses.
What is actually driving the increase in diagnoses.
EDS has historically been dramatically underdiagnosed. The average diagnostic delay has been documented at over a decade — meaning people spent ten or more years in the medical system before receiving a correct diagnosis. That gap is now, slowly, closing. What looks like a trend is in significant part a correction.
Increased awareness — including social media awareness — has helped people recognize patterns in their symptoms that they previously had no language for. They bring that language to their doctors. Some of those doctors diagnose appropriately. Some diagnose with limited understanding. And some dismiss the presentation entirely because they associate it with internet self-diagnosis and want no part of it.
hEDS — the most common subtype — does not yet have a confirmed genetic marker. This means it is diagnosed clinically, through a combination of criteria including the Beighton Score, systemic features, and family history. Without a definitive test, both overdiagnosis and underdiagnosis are genuinely possible. The solution is better clinician education, not dismissal of the diagnosis.
Biomechanical hypermobility: real symptoms, different cause.
There is a population of people whose hypermobility is not caused by an underlying connective tissue disorder — it is biomechanical. Poor movement mechanics, deconditioning, and muscle imbalances can produce significant joint laxity and symptoms in people whose connective tissue is entirely typical. This is real. The symptoms are real. The pain is real. And the good news is that it is highly addressable through targeted movement and rehabilitation.
This population exists and deserves care. Conflating them with people who have genetic connective tissue disorders does not help anyone — including them. Someone with biomechanical hypermobility needs a different protocol than someone with hEDS. Treating them identically produces worse outcomes for both.
None of this — none of it — is about questioning whether someone is suffering. It is about being precise enough in our understanding to actually help. A person with biomechanical hypermobility deserves treatment that addresses that. A person with hEDS deserves treatment that accounts for the full complexity of a connective tissue disorder. The right diagnosis leads to the right care.
What the EDS community deserves.
People who have spent years — sometimes decades — fighting to be diagnosed with EDS have earned the right to feel frustrated when their condition becomes a social media trend. That frustration is valid. Being dismissed as trendy after being dismissed as imaginary is a particularly cruel second blow.
At the same time, increased visibility has helped real people find answers they had been denied. It has led to more diagnoses — some appropriate, some not. The appropriate ones represent real people finally getting the care they needed. That matters.
What to do if you are in the middle of this.
If you have a confirmed EDS diagnosis: Your diagnosis is valid. The noise does not change your reality or your history. You are not obligated to defend the legitimacy of your condition every time someone calls it a trend.
If you suspect you have EDS or HSD: Seek evaluation from a provider who is genuinely knowledgeable about connective tissue disorders — not one who dismisses, and not one who diagnoses carelessly. The Ehlers-Danlos Society maintains a list of healthcare professionals familiar with the condition.
If you have symptomatic hypermobility without a formal diagnosis: You still deserve care. Symptomatic hypermobility — whatever its cause — is a real functional problem with real solutions. The label matters less than getting the right support.
vEDS — vascular EDS — is a subtype that carries serious cardiovascular risk and can be fatal without appropriate monitoring. It is rare but real. The tendency to treat all EDS as a social media trend has consequences for people with vEDS who struggle to be taken seriously by providers who associate the diagnosis with overdiagnosis. This is one of the most tangible clinical harms of the trend narrative.
EDS is not a trend. It is a real, genetic, multi-system connective tissue disorder that was dramatically underdiagnosed for decades. The current increase in diagnoses reflects a long-overdue correction — complicated by genuinely imperfect clinical knowledge and the realities of how health information spreads online. The people living with it deserve to have all of this held carefully: their decades of dismissal, their current frustration, and the reality that better visibility can lead to better outcomes — when matched with better medicine. Every person in this conversation deserves to be seen.